ATM and the epigenetics of the neuronal genome

Mechanisms of Ageing and Development

Volumn 134, Issue 10, 2013, Pages 434-439

  Herrup, Karl ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Cell cycle; Histone deacetylase; LTP; Neurodegeneration; Synaptic vesicle

Indexed keywords

ATM PROTEIN; DNA; HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 4; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; ATAXIA TELANGIECTASIA; CELL CYCLE; CELL DEATH; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; DEACETYLATION; DNA DAMAGE; DNA REPAIR; EPIGENETICS; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; NERVE CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYNAPSE VESICLE;

ATAXIA TELANGIECTASIA;

CELL CYCLE; HISTONE DEACETYLASE; LTP; NEURODEGENERATION; SYNAPTIC VESICLE;

ANIMALS; ATAXIA TELANGIECTASIA; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; EPIGENESIS, GENETIC; GENOME, HUMAN; HISTONE DEACETYLASES; HUMANS; NEURONS; REPRESSOR PROTEINS; SYNAPTIC VESICLES;

EID: 84888134806     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2013.05.005     Document Type: Article

References (81)

1. al-Ubaidi M.R., Hollyfield J.G., Overbeek P.A., Baehr W. Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(4):1194-1198.
2. Arendt T., Rodel L., Gartner U., Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 1996, 7(18):3047-3049.
3. Arendt T., Brückner M., Gertz H-J., Marcova L. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain. Neuroscience 1998, 83:991-1002.
4. Arendt T., Holzer M., Gartner U. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease. Journal of Neural Transmission 1998, 105(8/9):949-960.
5. Arendt T., Bruckner M., Mosch B., Losche A. Selective cell death of hyperploid neurons in Alzheimer's disease. The American Journal of Pathology 2010, 177(1):15-20.
6. Barlow C., Ribaut-Barassin C., Zwingman T.A., Pope A.J., Brown K.D., Owens J.W., et al. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(2):871-876.
7. Barnes D.E., Stamp G., Rosewell I., Denzel A., Lindahl T. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Current Biology 1998, 8(25):1395-1398.
8. Bertos N.R., Wang A.H., Yang X.J. Class II histone deacetylases: structure, function, and regulation. Biochemistry and Cell Biology 2001, 79(3):243-252.
9. Biton S., Dar I., Mittelman L., Pereg Y., Barzilai A., Shiloh Y. Nuclear ataxia-telangiectasia mutated (ATM) mediates the cellular response to DNA double strand breaks in human neuron-like cells. The Journal of Biological Chemistry 2006, 281(25):17482-17491.
10. Busser J., Geldmacher D.S., Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. The Journal of Neuroscience 1998, 18(8):2801-2807.
11. Chen B., Cepko C.L. HDAC4 regulates neuronal survival in normal and diseased retinas. Science 2009, 323(5911):256-259.
12. Cicero S., Herrup K. Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation. The Journal of Neuroscience 2005, 25(42):9658-9668.
13. Clarke A.R., Maandag E.R., van Roon M., van der Lugt N.M., van der Valk M., Hooper M.L., et al. Requirement for a functional Rb-1 gene in murine development. Nature 1992, 359(6393):328-330.
14. Darcy M.J., Calvin K., Cavnar K., Ouimet C.C. Regional and subcellular distribution of HDAC4 in mouse brain. The Journal of Comparative Neurology 2010, 518(5):722-740.
15. Feddersen R.M., Ehlenfeldt R., Yunis W.S., Clark H.B., Orr H.T. Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40T antigen transgenic mice. Neuron 1992, 9(5):955-966.
16. Feddersen R.M., Clark H.B., Yunis W.S., Orr H.T. In vivo viability of postmitotic Purkinje neurons requires pRb family member function. Molecular and Cellular Neurosciences 1995, 6(2):153-167.
17. Feddersen R.M., Yunis W.S., O'Donnell M.A., Ebner T.J., Shen L., Iadecola C., et al. Susceptibility to cell death induced by mutant SV40 T-antigen correlates with Purkinje neuron functional development. Molecular and Cellular Neurosciences 1997, 9(1):42-62.
18. Flavell S.W., Kim T.K., Gray J.M., Harmin D.A., Hemberg M., Hong E.J., et al. Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron 2008, 60(6):1022-1038.
19. Gao Y., Chaudhuri J., Zhu C., Davidson L., Weaver D.T., Alt F.W. A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination. Immunity 1998, 9(3):367-376.
20. Gilmore E.C., Nowakowski R.S., Caviness V.S., Herrup K. Cell birth, cell death, cell diversity and DNA breaks: how do they all fit together?. Trends in Neurosciences 2000, 23(3):100-105.
21. Grozinger C.M., Hassig C.A., Schreiber S.L. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(9):4868-4873.
22. Herrup K., Busser J.C. The induction of multiple cell cycle events precedes target-related neuronal death. Development 1995, 121(8):2385-2395.
23. Hoche F., Seidel K., Theis M., Vlaho S., Schubert R., Zielen S., et al. Neurodegeneration in ataxia telangiectasia: what is new? What is evident?. Neuropediatrics 2012, 43(3):119-129.
24. Hoglinger G.U., Breunig J.J., Depboylu C., Rouaux C., Michel P.P., Alvarez-Fischer D., et al. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(9):3585-3590.
25. Hoozemans J.J., Bruckner M.K., Rozemuller A.J., Veerhuis R., Eikelenboom P., Arendt T. Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. Journal of Neuropathology and Experimental Neurology 2002, 61(8):678-688.
26. Jacks T., Fazeli A., Schmitt E.M., Bronson R.T., Goodell M.A., Weinberg R.A. Effects of an Rb mutation in the mouse. Nature 1992, 359(6393):295-300.
27. Jordan-Sciutto K., Rhodes J., Bowser R. Altered subcellular distribution of transcriptional regulators in response to Abeta peptide and during Alzheimer's disease. Mechanisms of Ageing and Development 2001, 123(1):11-20.
28. Jordan-Sciutto K.L., Dorsey R., Chalovich E.M., Hammond R.R., Achim C.L. Expression patterns of retinoblastoma protein in Parkinson disease. Journal of Neuropathology and Experimental Neurology 2003, 62(1):68-74.
29. Kruman I.I., Wersto R.P., Cardozo-Pelaez F., Smilenov L., Chan S.L., Chrest F.J., et al. Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 2004, 41(4):549-561.
30. Lee E.Y., Chang C.Y., Hu N., Wang Y.C., Lai C.C., Herrup K., et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992, 359(6393):288-294.
31. Levine-Small N., Yekutieli Z., Aljadeff J., Boccaletti S., Ben-Jacob E., Barzilai A. Reduced synchronization persistence in neural networks derived from atm-deficient mice. Frontiers in Neuroscience 2011, 5:46.
32. Li J., Han Y.R., Plummer M.R., Herrup K. Cytoplasmic ATM in neurons modulates synaptic function. Current Biology 2009, 19(24):2091-2096.
33. Li J., Chen J., Vinters H.V., Gatti R.A., Herrup K. Stable brain ATM message and residual kinase-active ATM protein in ataxia-telangiectasia. The Journal of Neuroscience 2011, 31(20):7568-7577.
34. Lim D.S., Kirsch D.G., Canman C.E., Ahn J.H., Ziv Y., Newman L.S., et al. ATM binds to beta-adaptin in cytoplasmic vesicles. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(17):10146-10151.
35. Love S. Neuronal expression of cell cycle-related proteins after brain ischaemia in man. Neuroscience Letters 2003, 353(1):29-32.
36. Majdzadeh N., Wang L., Morrison B.E., Bassel-Duby R., Olson E.N., D'Mello S.R. HDAC4 inhibits cell-cycle progression and protects neurons from cell death. Developmental Neurobiology 2008, 68(8):1076-1092.
37. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316(5828):1160-1166.
38. McConnell M.J., Kaushal D., Yang A.H., Kingsbury M.A., Rehen S.K., Treuner K., et al. Failed clearance of aneuploid embryonic neural progenitor cells leads to excess aneuploidy in the Atm-deficient but not the Trp53-deficient adult cerebral cortex. The Journal of Neuroscience 2004, 24(37):8090-8096.
39. McKinsey T.A., Zhang C.L., Olson E.N. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(26):14400-14405.
40. McKinsey T.A., Zhang C.L., Lu J., Olson E.N. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 2000, 408(6808):106-111.
41. McShea A., Harris P.L., Webster K.R., Wahl A.F., Smith M.A. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. The American Journal of Pathology 1997, 150(6):1933-1939.
42. Menn B., Bach S., Blevins T.L., Campbell M., Meijer L., Timsit S. Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models. PLoS ONE 2010, 5(8):e12117.
43. Miska E.A., Karlsson C., Langley E., Nielsen S.J., Pines J., Kouzarides T. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO Journal 1999, 18(18):5099-5107.
44. Mosch B., Morawski M., Mittag A., Lenz D., Tarnok A., Arendt T. Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. The Journal of Neuroscience 2007, 27(26):6859-6867.
45. Mostofsky S.H., Kunze J.C., Cutting L.E., Lederman H.M., Denckla M.B. Judgment of duration in individuals with ataxia-telangiectasia. Developmental Neuropsychology 2000, 17(1):63-74.
46. Nagy Z., Esiri M.M., Smith A.D. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathologica 1997, 93(3):294-300.
47. Newman L.S., McKeever M.O., Okano H.J., Darnell R.B. Beta-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein. Cell 1995, 82(5):773-783.
48. Nguyen M.D., Boudreau M., Kriz J., Couillard-Despres S., Kaplan D.R., Julien J.P. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1. The Journal of Neuroscience 2003, 23(6):2131-2140.
49. O'Driscoll M., Jeggo P.A. The role of double-strand break repair - insights from human genetics. Nature reviews. Genetics 2006, 7(1):45-54.
50. Padmanabhan J., Park D.S., Greene L.A., Shelanski M.L. Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis. The Journal of Neuroscience 1999, 19(20):8747-8756.
51. Park D.S., Farinelli S.E., Greene L.A. Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons. The Journal of Biological Chemistry 1996, 271(14):8161-8169.
52. Park D.S., Levine B., Ferrari G., Greene L.A. Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. The Journal of Neuroscience 1997, 17(23):8975-8983.
53. Park D.S., Morris E.J., Greene L.A., Geller H.M. G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. The Journal of Neuroscience 1997, 17(4):1256-1270.
54. Park D.S., Morris E.J., Padmanabhan J., Shelanski M.L., Geller H.M., Greene L.A. Cyclin-dependent kinases participate in death of neurons evoked by DNA- damaging agents. The Journal of Cell Biology 1998, 143(2):457-467.
55. Park D.S., Morris E.J., Stefanis L., Troy C.M., Shelanski M.L., Geller H.M., et al. Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress. The Journal of Neuroscience 1998, 18(3):830-840.
56. Park D.S., Obeidat A., Giovanni A., Greene L.A. Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment. Neurobiology of Aging 2000, 21(6):771-781.
57. Ranganathan S., Bowser R. Alterations in G(1) to S Phase Cell-Cycle Regulators during Amyotrophic Lateral Sclerosis. The American Journal of Pathology 2003, 162(3):823-835.
58. Ranganathan S., Scudiere S., Bowser R. Hyperphosphorylation of the retinoblastoma gene product and altered subcellular distribution of E2F-1 during Alzheimer's disease and amyotrophic lateral sclerosis. Journal of Alzheimer's Disease 2001, 3(4):377-385.
59. Rimkus S.A., Katzenberger R.J., Trinh A.T., Dodson G.E., Tibbetts R.S., Wassarman D.A. Mutations in String/CDC25 inhibit cell cycle re-entry and neurodegeneration in a Drosophila model of Ataxia telangiectasia. Genes and Development 2008, 22(9):1205-1220.
60. Romito-DiGiacomo R.R., Menegay H., Cicero S.A., Herrup K. Effects of Alzheimer's disease on different cortical layers: the role of intrinsic differences in Abeta susceptibility. The Journal of Neuroscience 2007, 27(32):8496-8504.
61. Smith M.Z., Nagy Z., Esiri M.M. Cell cycle-related protein expression in vascular dementia and Alzheimer's disease. Neuroscience Letters 1999, 271(1):45-48.
62. Sugo N., Aratani Y., Nagashima Y., Kubota Y., Koyama H. Neonatal lethality with abnormal neurogenesis in mice deficient in DNA polymerase beta. EMBO Journal 2000, 19(6):1397-1404.
63. Valentin-Vega Y.A., Maclean K.H., Tait-Mulder J., Milasta S., Steeves M., Dorsey F.C., et al. Mitochondrial dysfunction in ataxia-telangiectasia. Blood 2012, 119(6):1490-1500.
64. Varvel N.H., Bhaskar K., Patil A.R., Pimplikar S.W., Herrup K., Lamb B.T. Abeta oligomers induce neuronal cell cycle events in Alzheimer's disease. The Journal of Neuroscience 2008, 28(43):10786-10793.
65. Varvel N.H., Bhaskar K., Kounnas M.Z., Wagner S.L., Yang Y., Lamb B.T., et al. NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. The Journal of Clinical Investigation 2009, 119(12):3692-3702.
66. Vega R.B., Matsuda K., Oh J., Barbosa A.C., Yang X., Meadows E., et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004, 119(4):555-566.
67. Vincent I., Rosado M., Davies P. Mitotic mechanisms in Alzheimer's disease?. Journal of Cell Biology 1996, 132(3):413-425.
68. Vincent I., Zheng J.H., Dickson D.W., Kress Y., Davies P. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiology of Aging 1998, 19(4):287-296.
69. Vinck A., Verhagen M.M., Gerven M., de Groot I.J., Weemaes C.M., Maassen B.A., et al. Cognitive and speech-language performance in children with ataxia telangiectasia. Developmental Neurorehabilitation 2011, 14(5):315-322.
70. Wang A.H., Yang X.J. Histone deacetylase 4 possesses intrinsic nuclear import and export signals. Molecular and Cellular Biology 2001, 21(17):5992-6005.
71. Wang A.H., Bertos N.R., Vezmar M., Pelletier N., Crosato M., Heng H.H., et al. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Molecular and Cellular Biology 1999, 19(11):7816-7827.
72. Watters D., Kedar P., Spring K., Bjorkman J., Chen P., Gatei M., et al. Localization of a portion of extranuclear ATM to peroxisomes. The Journal of Biological Chemistry 1999, 274(48):34277-34282.
73. West A.B., Dawson V.L., Dawson T.M. To die or grow: Parkinson's disease and cancer. Trends in Neurosciences 2005, 28(7):348-352.
74. Wu Q., Combs C., Cannady S.B., Geldmacher D.S., Herrup K. Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons. Neurobiology of Aging 2000, 21(6):797-806.
75. Yang Y., Herrup K. Loss of neuronal cell cycle control in ataxia-telangiectasia: a unified disease mechanism. The Journal of Neuroscience 2005, 25(10):2522-2529.
76. Yang Y., Geldmacher D.S., Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. The Journal of Neuroscience 2001, 21(8):2661-2668.
77. Yang Y., Mufson E.J., Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. The Journal of Neuroscience 2003, 23(7):2557-2563.
78. Yang Y., Varvel N.H., Lamb B.T., Herrup K. Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. The Journal of Neuroscience 2006, 26(3):775-784.
79. Yang J.L., Sykora P., Wilson D.M., Mattson M.P., Bohr V.A. The excitatory neurotransmitter glutamate stimulates DNA repair to increase neuronal resiliency. Mechanisms of Ageing and Development 2011, 132(8-9):405-411.
80. Zhao X., Ito A., Kane C.D., Liao T.S., Bolger T.A., Lemrow S.M., et al. The modular nature of histone deacetylase HDAC4 confers phosphorylation-dependent intracellular trafficking. The Journal of Biological Chemistry 2001, 276(37):35042-35048.
81. Zhu X., McShea A., Harris P.L., Raina A.K., Castellani R.J., Funk J.O., et al. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. Journal of Neuroscience Research 2004, 75(5):698-703.